SUBSCRIBE
SUBSCRIBE
News   Drug Development

7TM Pharma Has Initiated Phase I/IIa Clinical Trial with TM30339

September 2, 2008 | 
1 min read
7TM Pharma today announced that it has initiated a Phase I/IIa clinical trial with the drug candidate TM30339, which was discovered internally at 7TM Pharma and is being developed for treatment of obesity and related metabolic disorders.
Clinical research Phase 2
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Insights
Historic ALS Investment Signals New Treatment Momentum
February 23, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
Human hands holding colorful pieces of puzzle. Vector hand drawn sketch illustration. Business team solving problem, joining and connecting jigsaw. Teamwork, partnership, business solution concept
MASH
Beyond Rezdiffra: The 4 Most Promising MASH Pipelines in Play
February 23, 2026
 · 
6 min read
 · 
Ben Hargreaves